vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Zebra Technologies (ZBRA). Click either name above to swap in a different company.

Zebra Technologies is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× Alignment Healthcare, Inc.). Zebra Technologies runs the higher net margin — 4.7% vs 0.9%, a 3.8% gap on every dollar of revenue. On growth, Zebra Technologies posted the faster year-over-year revenue change (10.6% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 12.0%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Zebra Technologies Corporation (ZBR), commonly known as Zebra, is an American multinational technology conglomerate corporation specializing in smart data capture systems. Zebra is headquartered in Lincolnshire, Illinois outside of Chicago with 10,700 employees across 57 countries.

ALHC vs ZBRA — Head-to-Head

Bigger by revenue
ZBRA
ZBRA
1.2× larger
ZBRA
$1.5B
$1.2B
ALHC
Growing faster (revenue YoY)
ZBRA
ZBRA
+85.3% gap
ZBRA
10.6%
-74.7%
ALHC
Higher net margin
ZBRA
ZBRA
3.8% more per $
ZBRA
4.7%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
12.0%
ZBRA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALHC
ALHC
ZBRA
ZBRA
Revenue
$1.2B
$1.5B
Net Profit
$11.4M
$70.0M
Gross Margin
47.3%
Operating Margin
9.4%
Net Margin
0.9%
4.7%
Revenue YoY
-74.7%
10.6%
Net Profit YoY
-57.1%
EPS (diluted)
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
ZBRA
ZBRA
Q1 26
$1.2B
Q4 25
$1.0B
$1.5B
Q3 25
$993.7M
$1.3B
Q2 25
$1.0B
$1.3B
Q1 25
$926.9M
$1.3B
Q4 24
$701.2M
$1.3B
Q3 24
$692.4M
$1.3B
Q2 24
$681.3M
$1.2B
Net Profit
ALHC
ALHC
ZBRA
ZBRA
Q1 26
$11.4M
Q4 25
$-11.0M
$70.0M
Q3 25
$3.7M
$101.0M
Q2 25
$15.7M
$112.0M
Q1 25
$-9.1M
$136.0M
Q4 24
$-31.1M
$163.0M
Q3 24
$-26.4M
$137.0M
Q2 24
$-24.0M
$113.0M
Gross Margin
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
47.3%
Q3 25
48.0%
Q2 25
47.6%
Q1 25
49.3%
Q4 24
48.6%
Q3 24
48.8%
Q2 24
48.4%
Operating Margin
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
-1.0%
9.4%
Q3 25
0.8%
13.9%
Q2 25
2.2%
14.2%
Q1 25
-0.6%
14.9%
Q4 24
-3.2%
16.9%
Q3 24
-2.8%
15.2%
Q2 24
-2.7%
13.7%
Net Margin
ALHC
ALHC
ZBRA
ZBRA
Q1 26
0.9%
Q4 25
-1.1%
4.7%
Q3 25
0.4%
7.7%
Q2 25
1.5%
8.7%
Q1 25
-1.0%
10.4%
Q4 24
-4.4%
12.2%
Q3 24
-3.8%
10.9%
Q2 24
-3.5%
9.3%
EPS (diluted)
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
$-0.04
$1.40
Q3 25
$0.02
$1.97
Q2 25
$0.07
$2.19
Q1 25
$-0.05
$2.62
Q4 24
$-0.15
$3.14
Q3 24
$-0.14
$2.64
Q2 24
$-0.13
$2.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
ZBRA
ZBRA
Cash + ST InvestmentsLiquidity on hand
$705.6M
$125.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$3.6B
Total Assets
$1.3B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
ZBRA
ZBRA
Q1 26
$705.6M
Q4 25
$604.2M
$125.0M
Q3 25
$644.1M
$1.1B
Q2 25
$503.8M
$872.0M
Q1 25
$479.5M
$879.0M
Q4 24
$470.6M
$901.0M
Q3 24
$381.0M
$676.0M
Q2 24
$363.7M
$411.0M
Total Debt
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
$2.2B
Q2 25
$322.3M
$2.2B
Q1 25
$321.9M
$2.2B
Q4 24
$321.4M
Q3 24
$212.0M
$2.2B
Q2 24
$211.7M
$2.2B
Stockholders' Equity
ALHC
ALHC
ZBRA
ZBRA
Q1 26
$206.9M
Q4 25
$179.3M
$3.6B
Q3 25
$161.9M
$3.7B
Q2 25
$141.0M
$3.6B
Q1 25
$108.1M
$3.6B
Q4 24
$99.9M
$3.6B
Q3 24
$114.5M
$3.4B
Q2 24
$123.7M
$3.3B
Total Assets
ALHC
ALHC
ZBRA
ZBRA
Q1 26
$1.3B
Q4 25
$1.1B
$8.5B
Q3 25
$1.1B
$8.1B
Q2 25
$1.0B
$7.9B
Q1 25
$895.6M
$7.9B
Q4 24
$782.1M
$8.0B
Q3 24
$692.3M
$7.7B
Q2 24
$716.3M
$7.5B
Debt / Equity
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
1.80×
Q3 25
1.99×
0.58×
Q2 25
2.29×
0.60×
Q1 25
2.98×
0.60×
Q4 24
3.22×
Q3 24
1.85×
0.64×
Q2 24
1.71×
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
ZBRA
ZBRA
Operating Cash FlowLast quarter
$128.7M
$357.0M
Free Cash FlowOCF − Capex
$327.0M
FCF MarginFCF / Revenue
22.2%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
11.27×
5.10×
TTM Free Cash FlowTrailing 4 quarters
$831.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
ZBRA
ZBRA
Q1 26
$128.7M
Q4 25
$-50.4M
$357.0M
Q3 25
$144.6M
$235.0M
Q2 25
$29.1M
$147.0M
Q1 25
$16.6M
$178.0M
Q4 24
$-8.7M
$306.0M
Q3 24
$26.2M
$294.0M
Q2 24
$23.5M
$288.0M
Free Cash Flow
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
$-55.4M
$327.0M
Q3 25
$139.1M
$216.0M
Q2 25
$21.1M
$130.0M
Q1 25
$8.4M
$158.0M
Q4 24
$-18.0M
$288.0M
Q3 24
$16.9M
$277.0M
Q2 24
$11.8M
$278.0M
FCF Margin
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
-5.5%
22.2%
Q3 25
14.0%
16.4%
Q2 25
2.1%
10.1%
Q1 25
0.9%
12.1%
Q4 24
-2.6%
21.6%
Q3 24
2.4%
22.1%
Q2 24
1.7%
22.8%
Capex Intensity
ALHC
ALHC
ZBRA
ZBRA
Q1 26
Q4 25
0.5%
2.0%
Q3 25
0.6%
1.4%
Q2 25
0.8%
1.3%
Q1 25
0.9%
1.5%
Q4 24
1.3%
1.3%
Q3 24
1.3%
1.4%
Q2 24
1.7%
0.8%
Cash Conversion
ALHC
ALHC
ZBRA
ZBRA
Q1 26
11.27×
Q4 25
5.10×
Q3 25
38.77×
2.33×
Q2 25
1.86×
1.31×
Q1 25
1.31×
Q4 24
1.88×
Q3 24
2.15×
Q2 24
2.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

ZBRA
ZBRA

Tangible Products$1.2B83%
Service And Software$255.0M17%

Related Comparisons